Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab.

Giulia PaselloMartina LorenziLorenzo CalvettiCristina OlianiAlberto PavanAdolfo FavarettoGiovanni PalazzoloPetros GiovanisFable ZustovichAndrea BonettiDaniele BernardiMarta MandaràGiuseppe AprileGiovanna CrivellaroGiusy SinigagliaSandro TognazzoPaolo MorandiAlberto BortolamiValentina MarinoLaura BonannoValentina GuarneriPierFranco Conte

Published in: The oncologist (2022)

We defined predictors and prognostic-economic impact of nivolumab in etd patients.

Keyphrases

end stage renal disease
ejection fraction
randomized controlled trial
chronic kidney disease
systematic review
patient reported outcomes